Stock Price
40.84
Daily Change
-1.93 -4.51%
Monthly
14.53%
Yearly
21.51%
Q1 Forecast
42.71

Moderna reported $332M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
Agios Pharmaceuticals USD 32.03M 1.19M Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Biogen USD 2.21B 64.9M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Celltrion KRW 2.71T 121.94B Jun/2025
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Incyte USD 83.45M 24K Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Kangmei Pharma CNY 2.45B 12.27M Sep/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Moderna USD 332M 92M Sep/2025
Organigram Holdings CAD 123.95M 1.24M Sep/2025
Pharma Mar EUR 49.5M 1.02M Jun/2025
Qiagen NV USD 290.23M 2.32M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
Sartorius EUR 827.9M 30.5M Sep/2025
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Ultragenyx Pharmaceutical USD 52.2M 5.7M Sep/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025
Zz Pientze Pharmaceu CNY 5.72B 778.27M Jun/2025